ArticleScientific data2026
A longitudinal whole-body CT dataset with manually annotated tumor lesions.
Article in Scientific data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
We introduce Longitudinal-CT, a publicly available resource of whole-body computed tomography (CT) studies with exhaustive expert manual annotations of tumor lesions across two timepoints. The dataset comprises 600 CT studies from 300 patients diagnosed with metastatic malignant melanoma, each including a baseline and a follow-up examination acquired during systemic therapy at the University Hospital Tübingen, Germany. In total, it contains 7,182 manually segmented tumor lesions - 4,079 at baseline and 3,103 at follow-up - each labeled with anatomical location, volume, and longitudinal correspondence to capture lesion evolution such as persistence, regression, merging, or new appearance. All CT data are provided in anonymized NIfTI format with corresponding segmentation masks and lesion metadata. Longitudinal-CT establishes a standardized foundation for developing and validating artificial intelligence methods for automated lesion detection, segmentation, and temporal tracking in oncology. As a reference, a baseline deep learning segmentation model trained using nnU-Net v2 demonstrates the dataset's potential for advancing research in automated oncologic whole-body CT lesion segmentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.